Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Neogen

Neogen (NASDAQ: NEOG) insider transactions

In the twelve months to 10 November 2026, executives and directors of Neogen reported 1 open-market sale of 9,051 shares ($114,676) and 6 open-market purchases of 1,084 shares ($12,421), by 2 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Neogen shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
4 November 2026Yarwood JeremyChief Scientific OfficerOpen-market sale−9,051$12.670Form 4
3 November 2026Yarwood JeremyChief Scientific OfficerOption exercise+16,207$11.8216,207Form 4
3 November 2026Yarwood JeremyChief Scientific OfficerShares withheld for tax−7,156$11.829,051Form 4
2 November 2026Freels Joe BChief Commercial OfficerGrant or award+6,345$11.826,345Form 4
29 October 2026Borel James CDirectorOption exercise+1,776$12.21106,737Form 4
29 October 2026Capello Jeffrey DDirectorOption exercise+1,776$12.2142,892Form 4
29 October 2026Green Ronald DDirectorOption exercise+1,776$12.2129,044Form 4
29 October 2026Gupta AashimaDirectorOption exercise+1,776$12.2138,180Form 4
29 October 2026Rodriguez Rafael ADirectorOption exercise+1,776$12.2131,211Form 4
29 October 2026Woteki Catherine EDirectorOption exercise+1,776$12.2129,507Form 4
29 October 2026Hastings Gregory SVP, Animal HealthOption exercise+1,211$12.2133,786Form 4
29 October 2026Hastings Gregory SVP, Animal HealthShares withheld for tax−337$12.2133,449Form 4
14 October 2026Hastings Gregory SVP, Animal HealthOption exercise+287$12.0032,655Form 4
14 October 2026Hastings Gregory SVP, Animal HealthShares withheld for tax−80$12.0032,575Form 4
9 October 2026Nassif MikhealCEOOpen-market purchase+505$11.951,579Form 4
1 October 2026Borel James CDirectorGrant or award+9,804$12.24106,151Form 4
1 October 2026Capello Jeffrey DDirectorGrant or award+9,804$12.2442,306Form 4
1 October 2026Green Ronald DDirectorGrant or award+9,804$12.2428,458Form 4
1 October 2026Gupta AashimaDirectorGrant or award+9,804$12.2437,594Form 4
1 October 2026Pelossof AviDirectorGrant or award+9,804$12.249,804Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Neogen page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.